BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8149657)

  • 1. Absence of autoantibodies against glutamate decarboxylase (GAD) in the non-obese diabetic (NOD) mouse and low expression of the enzyme in mouse islets.
    Velloso LA; Eizirik DL; Karlsson FA; Kämpe O
    Clin Exp Immunol; 1994 Apr; 96(1):129-37. PubMed ID: 8149657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human autoantibodies react with glutamic acid decarboxylase antigen in human and rat but not in mouse pancreatic islets.
    Velloso LA; Kämpe O; Eizirik DL; Hallberg A; Andersson A; Karlsson FA
    Diabetologia; 1993 Jan; 36(1):39-46. PubMed ID: 8436251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
    De Aizpurua HJ; French MB; Chosich N; Harrison LC
    J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies specific to the glutamic acid decarboxylase 65 kDa isoform derived from a non-obese diabetic (NOD) mouse.
    Ziegler B; Augstein P; Lühder F; Northemann W; Hamann J; Schlosser M; Klöting I; Michaelis D; Ziegler M
    Diabetes Res; 1994; 25(2):47-64. PubMed ID: 7544254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets.
    Kim J; Richter W; Aanstoot HJ; Shi Y; Fu Q; Rajotte R; Warnock G; Baekkeskov S
    Diabetes; 1993 Dec; 42(12):1799-808. PubMed ID: 8243826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice.
    Petersen JS; Karlsen AE; Markholst H; Worsaae A; Dyrberg T; Michelsen B
    Diabetes; 1994 Dec; 43(12):1478-84. PubMed ID: 7958502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression.
    Velloso LA; Kämpe O; Hallberg A; Christmanson L; Betsholtz C; Karlsson FA
    J Clin Invest; 1993 May; 91(5):2084-90. PubMed ID: 8486775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells.
    Yoon JW; Yoon CS; Lim HW; Huang QQ; Kang Y; Pyun KH; Hirasawa K; Sherwin RS; Jun HS
    Science; 1999 May; 284(5417):1183-7. PubMed ID: 10325232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
    Chaillous L; Delamaire M; Martignat L; Maugendre D; Marre M; Mathieu E; Limal JM; Charbonnel B; Allannic H; Saï P
    Diabetes Care; 1994 Oct; 17(10):1115-23. PubMed ID: 7821130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes.
    Björk E; Velloso LA; Kämpe O; Karlsson FA
    Diabetes; 1994 Jan; 43(1):161-5. PubMed ID: 7505244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
    Ziegler B; Schlosser M; Lühder F; Strebelow M; Augstein P; Northemann W; Powers AC; Ziegler M
    Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant glutamic acid decarboxylase (representing the single isoform expressed in human islets) detects IDDM-associated 64,000-M(r) autoantibodies.
    Karlsen AE; Hagopian WA; Petersen JS; Boel E; Dyrberg T; Grubin CE; Michelsen BK; Madsen OD; Lernmark A
    Diabetes; 1992 Oct; 41(10):1355-9. PubMed ID: 1397711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning, characterization, and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent diabetes mellitus.
    Michelsen BK; Petersen JS; Boel E; Møldrup A; Dyrberg T; Madsen OD
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8754-8. PubMed ID: 1924335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice.
    Elliott JF; Qin HY; Bhatti S; Smith DK; Singh RK; Dillon T; Lauzon J; Singh B
    Diabetes; 1994 Dec; 43(12):1494-9. PubMed ID: 7525393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cells with multiple fine specificities are used by non-obese diabetic (NOD) mice in the response to GAD(524-543).
    Quinn A; Sercarz EE
    J Autoimmun; 1996 Jun; 9(3):365-70. PubMed ID: 8816972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of nonobese diabetic mouse T-cells that recognize novel autoantigens involved in the early events of diabetes.
    Gelber C; Paborsky L; Singer S; McAteer D; Tisch R; Jolicoeur C; Buelow R; McDevitt H; Fathman CG
    Diabetes; 1994 Jan; 43(1):33-9. PubMed ID: 8262314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of autoimmune diabetes in nonobese diabetic female mice by treatment with recombinant glutamic acid decarboxylase (GAD 65).
    Pleau JM; Fernandez-Saravia F; Esling A; Homo-Delarche F; Dardenne M
    Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):90-5. PubMed ID: 7606872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease.
    Geng L; Solimena M; Flavell RA; Sherwin RS; Hayday AC
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10055-60. PubMed ID: 9707599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.
    Tisch R; Yang XD; Singer SM; Liblau RS; Fugger L; McDevitt HO
    Nature; 1993 Nov; 366(6450):72-5. PubMed ID: 8232539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes.
    Saï P; Rivereau AS; Granier C; Haertlé T; Martignat L
    Clin Exp Immunol; 1996 Aug; 105(2):330-7. PubMed ID: 8706342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.